The visit is a price, not an inclusion
The evaluation and the follow-up each carry their own figure, and the page says the follow-ups are typically scheduled every four to eight weeks. That is enough to build a running cost rather than a first-month cost.
We have stored both as fee rows that do not cover medication, so nothing on this site can add a visit fee to a drug price and present the total as a medication rate. Eleven of the one hundred and fifty-eight sellers here publish a figure that is not the medication.
A reader comparing this against a flat all-in seller is not comparing like with like until the evaluation and the follow-ups are added in.
An oral tier and an injection tier, both banded
Both routes are priced in three bands — a starter plan, an intermediate plan and a higher-dose plan — with the oral tablet cheaper at the bottom and the two converging at the top. Twenty-seven of the one hundred and fifty-eight sellers here price an oral route at all.
The bands are described by plan rather than by milligrams, so a reader cannot map their own prescribed dose onto a tier without asking. That is a real gap in an otherwise unusually explicit price list.
Both preparations are described as carrying B12 alongside the semaglutide, which is a combination product rather than the plain drug.
A Texas practice with a named entity
The Notice of Privacy Practices names the operating limited liability company and gives a street address. The page title and the service description both localise it to Texas, and the page's own headline names the state.
No compounding pharmacy is named and no individual prescriber is named on the priced page, which puts this seller in the larger group on both counts.
One host note worth recording: a nonsense path here returns a not-found status carrying more than four thousand characters of visible shell text. Anything judged by response size on this domain would confirm an address that does not exist.
Wholesome Clinic's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded-oral) | $109/mostarter plan for the oral tablet; the same page prices an intermediate plan at $149 and a higher-dose plan at $199 a month | September 2026source |
| Semaglutide (compounded) | $149/mostarter plan for the injection; intermediate $169 and higher-dose from $199 a month on the same page | September 2026source |
| Glp-1 (compounded) | $149a one-off evaluation fee, not a medication price and not a monthly rate | September 2026source |
| Glp-1 (compounded) | $75a follow-up visit fee, which the page says is typically scheduled every four to eight weeks; a fee, not a medication price | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Wholesome Clinic's current price →Good fit if
- Texas buyers who want the visit cost and the drug cost quoted separately.
- Readers who want to know how often follow-up appointments fall before starting.
- People who want an oral option priced against an injection by the same clinic.
Look elsewhere if
- Anyone outside Texas.
- Buyers who want their prescribed dose mapped to a price band in milligrams.
- Readers who want the compounding pharmacy named.
- People who want one all-in figure rather than four separate charges.
How this review was verified
- Read the Texas telehealth page and the Notice of Privacy Practices on 6 September 2026, comparing requested to effective paths, with a nonsense-path control on the host in the same run.
- Recorded the not-found control's four thousand characters of body text, which is why nothing on this host was judged by response size.
- Stored the evaluation and the follow-up as fee rows that do not cover medication, so no total on this site can treat either as a drug price.
- Took the plan band figures from the page that lists them rather than from the page heading, which quotes only one of them.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.